找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Early Gastrointestinal Cancers II: Rectal Cancer; Florian Otto,Manfred P. Lutz Book 2014 Springer International Publishing Switzerland 201

[复制链接]
楼主: Definite
发表于 2025-3-27 00:57:14 | 显示全部楼层
https://doi.org/10.1007/978-90-313-9647-4f early stage tumours is likely to increase following greater implementation in screening programs. The goal of this invited review is to provide recommendations based on the consensus discussion on the information from preoperative imaging that is of relevance for clinical decision-making for patients with early rectal cancer.
发表于 2025-3-27 03:45:56 | 显示全部楼层
发表于 2025-3-27 07:55:33 | 显示全部楼层
Book 2014 well as colorectal cancer with synchronous resectable liver metastases. The contents comprise the majority of the invited contributions from the Second St. Gallen EORTC Gastrointestinal Cancer Conference, held on 6-8 March 2014 in St. Gallen, Switzerland. Written by some of the world’s leading expe
发表于 2025-3-27 12:38:09 | 显示全部楼层
发表于 2025-3-27 17:27:38 | 显示全部楼层
发表于 2025-3-27 18:23:59 | 显示全部楼层
发表于 2025-3-27 22:03:28 | 显示全部楼层
发表于 2025-3-28 03:57:53 | 显示全部楼层
https://doi.org/10.1007/978-3-662-24753-2erative outcomes and similar oncologic results. However, the conversion rate of LTME is around 17 %. The literature supporting RTME is more limited. Robotic rectal resection appears to have similar postoperative and oncologic outcomes compared to LTME. RTME results in higher costs and possibly lower
发表于 2025-3-28 07:30:32 | 显示全部楼层
https://doi.org/10.1007/978-3-7091-5380-2lled surgery in terms of total mesorectal excision (TME) in the trial setting can be associated with much lower local recurrence rates of less than 10 % whether patients receive radiotherapy or not. Because of the high risk of metastatic disease in selected patients, integrating more active chemothe
发表于 2025-3-28 12:04:14 | 显示全部楼层
,Arbeitsplan und Bauart der Versuchskörper,oadjuvant therapy (50 %). The most frequently used instruments were the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (QLQ-C30), its colorectal cancer specific module QLQ-CR38, and the Medical Outcomes Study Short-Form 36 items questionnaire. Findin
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-22 14:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表